Name: in vivo tracking of human adipose-derived mesenchymal stem cells in a rat knee osteoarthritis model with fluorescent lipophilic membrane dye
Uploaded: 2017-10-08T14:00:00.000+00:00
Duration: 7 min 31 s
Description: Watch this Scientific Journal Video about In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye at JoVE.com

本研究由上海市科技委员会 (CN) 赞助的上海创新基金 (1402H294300) 资助, Dr.。感谢 Dr. 广东周 (中国国家组织工程中心) 对本论文的技术支持和科学建议。我们还要感谢 Mr. 矿泉夏 (上海第九人民医院) 在动物福利方面的帮助。

涉及动物的程序由当地机构动物保育和伦理委员会批准, 以尽量减少动物的痛苦。本协议由上海市交通大学医学院附属机构动物护理与使用委员会 (IACUC) 批准, 并与本协议编号 [2017] 063. 
 1. 手术诱发大鼠膝骨关节炎模型的建立 <ol> <li> 为此外科手术, 使用 8-12 周老雄性大 (SD) 大鼠, 体重介于250和300克之间。
	<li> 麻醉40毫克/千克 tiletamine 和40毫克/千克唑通过肌肉注射的动物. </li>
	<li> 将动物置于处于加热阶段的左侧面位置。用剃刀把右膝彻底剃掉。用 10% providone 碘溶液和70% 乙醇进行消毒, 再重复两次, 再涂上 10% providone 碘溶液, 用手术垫覆盖非手术区. </li>
	<li> 使用外科手术刀, 沿髌腱侧向2厘米切口以暴露 jointcapsules. </li>
	<li> 使用外科手术刀将内侧副韧带横断面。反映股骨半月板. </li>
	<li> 在手术过程中, 在关节软骨表面滴入无菌0.9% 氯化钠溶液, 防止软骨干燥. </li>
	<li> 用镊子抓住内侧半月板, 用手术刀从胫骨附件的最窄点切开半月板 ( 图 1A )。避免损伤软骨. </li>
	<li> 用 4-0 的可吸收缝合线关闭关节囊. </li>
	<li> 监控手术鼠, 直到他们恢复知觉. </li>
	<li> 注射20毫克/千克庆大霉素, 以防止感染和0.05 毫克/千克丁丙诺啡通过肌肉注射的途径, 以减轻疼痛后手术. </li>
	<li> 在一个温度控制的动物设施中, 在12小时的光照/暗循环下维持 3-8 周的大鼠 KOA。动物继续接受止痛药, 包括但不限于丁丙诺啡 (0.05 毫克/千克, 贝聿铭) 和庆大霉素 (20 毫克/千克, 贝聿铭), 如果疼痛症状持续. </li>
</ol> 2。大鼠 KOA 模型的组织学评价 <ol> <li> 牺牲过量 CO 的大鼠 2 吸入 (在腔室中增加每分钟容积约30% 的填充率与二氧化碳到现有空气中, 使动物失去知觉在呼吸停止后2-3 分钟内维持 CO2 流至少1分钟。在指定的时间点 (代表性的结果显示在8周的 KOA 诱导范围从3到8周) 后, 手术. 和 #160; </li> <li> 解剖膝盖关节周围的皮肤和肌肉, 用手术刀切断膝关节. </li>
	<li> 将4% 甲醛 (粉煤灰) 的膝关节固定在室温下3天。然后, decalcify 20% 乙酸乙酸 (edta) 中的样品, 在4和 #176 ° C 下进行约4周, 每3天更换一次 edta. 
	警告: 甲醛是有毒的, 穿戴适当的个人防护设备 (PPE), 如手套和眼镜. </li>
	<li> 使用自动组织处理器脱水样品。设置菜单开始一个冲洗周期如下: 70% 乙醇为 1 h;80% 乙醇和95% 乙醇分别为 1 h;其次2循环100% 乙醇为 1 h;随后, 二甲苯每次两次1小时, 石蜡3次在58和 #176; C 每次1小时. 
	注意: 二甲苯是有毒的, 所以佩戴适当的 PPE, 如手套和眼镜. 
	注: (可选) 使用 Coplin 罐进行手动脱水, 其设置与自动组织处理器相同. </li>
	<li> 将完整的关节面的内侧部分向下放置, 并将其嵌入到中心的石蜡块中. 
	注: 可选择使用镊子手动将样品嵌入石蜡块中. </li>
	<li> 开始切割5和 #181; 从关节内侧缘的矢状段到30和 #181; m 间隔, 由旋转切片2个连续部分. </li>
	<li> 在玻璃幻灯片上安装剖面并 deparaffinize 二甲苯中的幻灯片。在2个连续部分之间, 染色一张幻灯片与苏木精和 #38; 曙红 (H 和 #38; E) 染色: 0.1% 苏木精为 15 min, 1% 乙酸溶液为十年代和0.5% 次曙红为 10 min。和染色的其他幻灯片与红 o/快速绿色染色: 0.1% 苏木精为15分钟, 0.02% 快速绿色为3分钟, 1% 醋酸溶液为十年代和0.1% 红 O 为 3 min. 
	注意: 二甲苯有毒, 佩戴适当的 PPE, 如手套、眼镜. </li>
	<li> 使用骨关节炎研究协会国际 (OARSI) 大鼠组织病理学评估系统对彩色幻灯片进行评分 6 . </li>
</ol> 3。人骨髓间充质干细胞与荧光染料的标签做了 <ol> <li> 准备在100% 乙醇浓度为1毫米的细胞标记溶液。保护细胞标签的解决方案从光和存储在室温下6月. </li>
	<li> 在 Dulbecco 和 #39 中使用标准的单元格培养程序扩展 haMSCs; s 修饰的鹰和 #39; s 培养基 (DMEM), 辅以1% 青霉素和链霉素和10% 胎小牛血清 (FCS) 在10厘米的 petri 皿中. </li>
	<li> 分离 haMSCs 与2毫升0.25% 胰蛋白酶与1毫米 EDTA 在大约80% 汇合之前. </li>
	<li> 中和胰蛋白酶与4毫升培养基和旋转的细胞在 800 x g 在室温下3分钟. </li>
	<li> 在5毫升无血清培养基中, 以 1 x 10 6 细胞/毫升的密度将细胞挂起. </li>
	<li> 通过添加50和 #181 对单元格进行标记; 我在37和 #176 的5毫升无血清培养基中做了细胞标记液; C 为 50 min. </li>
	<li> 将标记的单元格在 800 x g 处旋转3分钟. </li>
	<li> 用5毫升磷酸酯缓冲盐水 (PBS) 在 800 x g 上再清洗两次电池, 每次3分钟. </li>
	<li> 使用 Cy5 过滤器设置的荧光显微镜检查标签 haMSCs. </li>
	<li> 将台盼蓝染色的单元格计数并获得 2.5 x 10 6 100 和 #181 中的活细胞; L PBS 注射. </li>
</ol> 4。 在体内 荧光成像跟踪 haMSCs <ol> <li> 手术后八周 (步骤 1), 麻醉 KOA 鼠肌肉注射25毫克/千克 tiletamine 和25毫克/千克唑. </li>
	<li> 用剃刀彻底剃掉右膝, 露出关节区域。用70% 乙醇对关节区域进行消毒. </li>
	<li> 使用 26 G 注射器针, 注入 2.5 x 10 6 标记的单元格在100和 #181 中挂起; L PBS 位于由髌韧带内侧侧、股骨内侧髁和胫骨内侧髁形成的三角形区域中心 ( 图 1B ). </li>
	<li> 打开图像软件并初始化 在体内的 生物发光成像系统. </li>
	<li> 将大鼠置于成像系统中央阶段的仰卧位, 并关闭室的门. </li>
	<li> 检查 #34; 荧光 #34; 复选框, 然后选择 640 nm 的荧光滤光片进行励磁, 680 nm 发射 ( 图 2A ). </li>
	<li> 选择视野到 d. 设置像素分到中 (8), F/停止到2和曝光时间自动。保持最佳在整个研究中获得可比较结果的曝光时间 ( 图 2A ). </li>
	<li> 将动物从舞台上移除, 并从麻醉中恢复. 
	注意: 将动物放在覆盖着2-3 层毛巾的加热垫上. </li>
	<li> 选择荧光测量的辐射效率单位 ( 图 2B )。选择感兴趣的区域 (ROI) 分析和量化每个图像的荧光信号 ( 图 2C ). </li>
	<li> 重复此过程 在体内 依次对每只老鼠进行成像, 以研究 haMSCs 在关节中的纵向保留. 
	注: 和 #160; 我们建议成像动物和 #39; 荧光信号的活体成像系统每两天一次注射后第一周和每周一次, 直到信号无法检测. </li>
</ol>

<ol>
	<li>Loeser, R. F., Goldring, S. R., Scanzello, C. R., Goldring, M. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Osteoarthritis:+a+disease+of+the+joint+as+an+organ.">Osteoarthritis: a disease of the joint as an organ.</a> Arthritis Rheum. 64 (6), 1697-1707 (2012).</li><li>Lane, N. E., Shidara, K., Wise, B. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Osteoarthritis+year+in+review+2016:+clinical.">Osteoarthritis year in review 2016: clinical.</a> Osteoarthritis Cartilage. 25 (2), 209-215 (2017).</li><li>Wang, W., Cao, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Treatment+of+osteoarthritis+with+mesenchymal+stem+cells.">Treatment of osteoarthritis with mesenchymal stem cells.</a> Sci China Life Sci. 57 (6), 586-595 (2014).</li><li>Burke, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+potential+of+mesenchymal+stem+cell+based+therapy+for+osteoarthritis.">Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis.</a> Clin Transl Med. 5 (1), 27 (2016).</li><li>Bendele, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Animal+models+of+osteoarthritis.">Animal models of osteoarthritis.</a> J Musculoskelet Neuronal Interact. 1 (4), 363-376 (2001).</li><li>Gerwin, N., Bendele, A. M., Glasson, S., Carlson, C. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+OARSI+histopathology+initiative+-+recommendations+for+histological+assessments+of+osteoarthritis+in+the+rat.">The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat.</a> Osteoarthritis Cartilage. 18, S24-S34 (2010).</li><li>Janusz, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induction+of+osteoarthritis+in+the+rat+by+surgical+tear+of+the+meniscus:+Inhibition+of+joint+damage+by+a+matrix+metalloproteinase+inhibitor.">Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor.</a> Osteoarthritis Cartilage. 10 (10), 785-791 (2002).</li><li>Li, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vivo+human+adipose-derived+mesenchymal+stem+cell+tracking+after+intra-articular+delivery+in+a+rat+osteoarthritis+model.">In vivo human adipose-derived mesenchymal stem cell tracking after intra-articular delivery in a rat osteoarthritis model.</a> Stem Cell Res Ther. 7 (1), 160 (2016).</li><li>Zhou, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Administering+human+adipose-derived+mesenchymal+stem+cells+to+prevent+and+treat+experimental+arthritis.">Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.</a> Clin Immunol. 141 (3), 328-337 (2011).</li><li>Desando, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intra-articular+delivery+of+adipose+derived+stromal+cells+attenuates+osteoarthritis+progression+in+an+experimental+rabbit+model.">Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model.</a> Arthritis Res Ther. 15 (1), 22 (2013).</li><li>Riester, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Safety+Studies+for+Use+of+Adipose+Tissue-Derived+Mesenchymal+Stromal/Stem+Cells+in+a+Rabbit+Model+for+Osteoarthritis+to+Support+a+Phase+I+Clinical+Trial.">Safety Studies for Use of Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells in a Rabbit Model for Osteoarthritis to Support a Phase I Clinical Trial.</a> Stem Cells Transl Med. 6 (3), 910-922 (2017).</li><li>Bai, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Tracking+long-term+survival+of+intramyocardially+delivered+human+adipose+tissue-derived+stem+cells+using+bioluminescence+imaging.">Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging.</a> Mol Imaging Biol. 13 (4), 633-645 (2011).</li><li>Wolbank, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Labelling+of+human+adipose-derived+stem+cells+for+non-invasive+in+vivo+cell+tracking.">Labelling of human adipose-derived stem cells for non-invasive in vivo cell tracking.</a> Cell Tissue Bank. 8 (3), 163-177 (2007).</li><li>Heymer, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Iron+oxide+labelling+of+human+mesenchymal+stem+cells+in+collagen+hydrogels+for+articular+cartilage+repair.">Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair.</a> Biomaterials. 29 (10), 1473-1483 (2008).</li><li>Hemmrich, K., Meersch, M., von Heimburg, D., Pallua, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Applicability+of+the+dyes+CFSE,+CM-DiI+and+PKH26+for+tracking+of+human+preadipocytes+to+evaluate+adipose+tissue+engineering.">Applicability of the dyes CFSE, CM-DiI and PKH26 for tracking of human preadipocytes to evaluate adipose tissue engineering.</a> Cells Tissues Organs. 184 (3-4), 117-127 (2006).</li><li>Shim, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pharmacokinetics+and+in+vivo+fate+of+intra-articularly+transplanted+human+bone+marrow-derived+clonal+mesenchymal+stem+cells.">Pharmacokinetics and in vivo fate of intra-articularly transplanted human bone marrow-derived clonal mesenchymal stem cells.</a> Stem Cells Dev. 24 (9), 1124-1132 (2015).</li><li>Chen, B. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+safety+study+on+intrathecal+delivery+of+autologous+mesenchymal+stromal+cells+in+rabbits+directly+supporting+Phase+I+human+trials.">A safety study on intrathecal delivery of autologous mesenchymal stromal cells in rabbits directly supporting Phase I human trials.</a> Transfusion. 55 (5), 1013-1020 (2015).</li><li>Chan, M. M., Gray, B. D., Pak, K. Y., Fong, D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Non-invasive+in+vivo+imaging+of+arthritis+in+a+collagen-induced+murine+model+with+phosphatidylserine-binding+near-infrared+(NIR)+dye.">Non-invasive in vivo imaging of arthritis in a collagen-induced murine model with phosphatidylserine-binding near-infrared (NIR) dye.</a> Arthritis Res Ther. 17, 50 (2015).</li><li>Texier, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cyanine-loaded+lipid+nanoparticles+for+improved+in+vivo+fluorescence+imaging.">Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging.</a> J Biomed Opt. 14 (5), 054005 (2009).</li><li>Honig, M. G., Hume, R. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Fluorescent+carbocyanine+dyes+allow+living+neurons+of+identified+origin+to+be+studied+in+long-term+cultures.">Fluorescent carbocyanine dyes allow living neurons of identified origin to be studied in long-term cultures.</a> J Cell Biol. 103 (1), 171-187 (1986).</li><li>Rahmati, M., Mobasheri, A., Mozafari, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inflammatory+mediators+in+osteoarthritis:+A+critical+review+of+the+state-of-the-art,+current+prospects,+and+future+challenges.">Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges.</a> Bone. 85, 81-90 (2016).</li><li>Detante, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intravenous+administration+of+99mTc-HMPAO-labeled+human+mesenchymal+stem+cells+after+stroke:+in+vivo+imaging+and+biodistribution.">Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution.</a> Cell Transplant. 18 (12), 1369-1379 (2009).</li><li>Hu, S. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vivo+magnetic+resonance+imaging+tracking+of+SPIO-labeled+human+umbilical+cord+mesenchymal+stem+cells.">In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells.</a> J Cell Biochem. 113 (3), 1005-1012 (2012).</li><li>Xia, Q., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intra-articular+transplantation+of+atsttrin-transduced+mesenchymal+stem+cells+ameliorate+osteoarthritis+development.">Intra-articular transplantation of atsttrin-transduced mesenchymal stem cells ameliorate osteoarthritis development.</a> Stem Cells Transl Med. 4 (5), 523-531 (2015).</li><li>Jasmin, , et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Optimized+labeling+of+bone+marrow+mesenchymal+cells+with+superparamagnetic+iron+oxide+nanoparticles+and+in+vivo+visualization+by+magnetic+resonance+imaging.">Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging.</a> J Nanobiotechnology. 9, 4 (2011).</li><li>Lehmann, T. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Coculture+of+human+nucleus+pulposus+cells+with+multipotent+mesenchymal+stromal+cells+from+human+bone+marrow+reveals+formation+of+tunnelling+nanotubes.">Coculture of human nucleus pulposus cells with multipotent mesenchymal stromal cells from human bone marrow reveals formation of tunnelling nanotubes.</a> Mol Med Rep. 9 (2), 574-582 (2014).</li><li>Wang, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+adipose-derived+mesenchymal+progenitor+cells+engraft+into+rabbit+articular+cartilage.">Human adipose-derived mesenchymal progenitor cells engraft into rabbit articular cartilage.</a> Int J Mol Sci. 16 (6), 12076-12091 (2015).</li></ol>

孟里、明浩和文王是目前的员工和细胞生物医学组的股票期权持有者 (纳斯达克: CBMG)。其他作者声明没有利益冲突。

我们迫切需要干细胞治疗的安全标准和分布研究, 才能将再生干细胞治疗 KOA 从长凳到床边。然而, 疾病的病理环境在移植 haMSCs 的持续和分布中起着重要作用10。最近, 我们的小组表明, 关节内注射 haMSCs 在病理 KOA 环境中的持续时间比正常情况下注射在8。炎症和退行性微环境可能会招募骨髓间充质干细胞进行修复, 随后有利于保留注入的 haMSCs1<s...

膝关节骨关节炎 (KOA) 是一种退行性疾病, 由关节软骨丧失和渐进炎症, 这已成为一个主要的慢性病在世界各地的老年人1。然而, 目前的治疗使用抗炎药物, 物理补充剂和手术程序可能只提供暂时缓解症状性疼痛2。
人脂肪源性间充质干细胞 (haMSCs) 已成为一种有希望的再生治疗膝关节骨性关节炎, 由于其多能分化潜能的软骨再生和免疫调节特性3, 4。与药理学途径, 以研究的作用机制的行为在体内, 跟踪活 haMSCs 在小 KOA 动物模型目前是有益的建立的理由和可行性 haMSC 治疗前的临床应用。在临床前测试中, 内侧切除 (MM) 破坏关节的机械负荷诱导大鼠 KOA, 提供了一个相对可行的模型, 具有一致的重现性5。KOA 诱发的早于前十字韧带横断, 或与部分内侧切除6相结合。因此, 在由 MM7、8引起的大鼠中, 通常会对注射 haMSCs 与 KOA 的病理微环境之间的长期相互作用进行评估。
虽然 haMSCs 的治疗效果已被广泛报道, 有关知识的体内持续的植入 haMSCs 通过关节内 (IA) 注射是稀缺的9,10。因此, 已经开发了各种细胞标记方法, 包括 immunohistology11、荧光12、绿色荧光蛋白13转染、氧化铁标记为磁共振成像 (MRI)14和众多荧光细胞染料8、15、16。与 labor-intensive 组织学分析相比,在体内非侵入性成像采用光学器件来检测标记有荧光信号的细胞的 real-time 分布和动态,1017。对于功能性活细胞成像, cytocompatible 荧光标记是一种先进的无放射性跟踪技术, 以揭示细胞活动后, 干细胞移植18。此外, 多色荧光亲油性染料具有相对于氨基活性亲水染料或荧光蛋白的优势, 包括其改进的细胞通透性和增强的荧光量子产率19。
因此, 这里所包含的协议使用红色激光激发带有亲油性 carbocyanines 的细胞 (DilC18(5)), 这是一个远红色荧光 Dil (dialkylcarbocyanines) 模拟20。红移激发和发射光谱的确有避免 autofluorescent 干扰, 并允许深层成像在很长一段时间的活动物8。这种跟踪细胞在体内的方法是有效的监测移植的干细胞, 如 haMSCs, 在动物模型, 这是必不可少的了解和改善现有的干细胞再生疗法。

<table><tbody><tr><td>Matrx VMR animal anesthesia system</td><td>Midmark</td><td>VIP3000</td><td></td></tr><tr><td>4-0 suture</td><td>Shanghai Jinhuan</td><td>KC439</td><td></td></tr><tr><td>Razor</td><td>Pritech</td><td>LD-9987</td><td></td></tr><tr><td>Gentamicin</td><td>Zhejiang Jindakang Animal Health Product Co., Ltd.</td><td>None</td><td></td></tr><tr><td>0.9% Sodium chloride solution</td><td>Hunan Kelun Pharmaceutical Co., Ltd.</td><td>H43020455</td><td></td></tr><tr><td>Penicillin</td><td>Shanghai Kangfu chemical pharmaceutical Co., Ltd.</td><td>None</td><td></td></tr><tr><td>Buprenorphine</td><td>Tianjin Pharmaceutical Research Institute Pharmaceutical Co., Ltd.</td><td>None</td><td></td></tr><tr><td>Paraformaldehyde</td><td>Sigma-Aldrich</td><td>16005</td><td>Dilute to final concentration of 10% in PBS</td></tr><tr><td>EDTA</td><td>Sigma-Aldrich</td><td>E9884</td><td>Dilute to final concentration of 20% in PBS</td></tr><tr><td>0.1% Hematoxylin Solution, Mayer&amp;rsquo;s</td><td>Sigma-Aldrich</td><td>MHS16</td><td></td></tr><tr><td>0.5% Eosin Y solution, alcoholic</td><td>Sigma-Aldrich</td><td>HT110116</td><td></td></tr><tr><td>Safranin O</td><td>Sigma-Aldrich</td><td>S8884</td><td></td></tr><tr><td>Fast Green</td><td>Sigma-Aldrich</td><td>F7258</td><td></td></tr><tr><td>Shandon Excelsior ESTM Tissue Processor</td><td>Thermo Fisher</td><td>A78400006</td><td></td></tr><tr><td>Shandon Histocentre&amp;trade; 3 Tissue Embedding Center</td><td>Thermo Fisher</td><td>B64100010</td><td></td></tr><tr><td>Fully Automated Rotary Microtome</td><td>Leica</td><td>RM2255</td><td></td></tr><tr><td>DiD</td><td>Molecular Probes, Life&lt;br/&gt; Technologies</td><td>V-22887</td><td></td></tr><tr><td>D-MEM High Glucose</td><td>Sigma-Aldrich</td><td>D5648</td><td></td></tr><tr><td>PBS</td><td>GIBCO, Life Technologies</td><td>14190-144</td><td></td></tr><tr><td>0.25% Trypsin-EDTA</td><td>Invitrogen</td><td>25200-114</td><td></td></tr><tr><td>10 cm Petri Dish</td><td>Corning</td><td>V118877</td><td></td></tr><tr><td>Centrifuge</td><td>Beckman</td><td>Optima MAX-TL</td><td></td></tr><tr><td>Fluorescent microscope</td><td>Olympus</td><td>BX53</td><td></td></tr><tr><td>0.4% Trypan Blue solution</td><td>Sigma-Aldrich</td><td>93595</td><td></td></tr><tr><td>Titetamme</td><td>Virbac (Zoletil 50)</td><td>1000000188</td><td></td></tr><tr><td>Zolazepam</td><td>Virbac (Zoletil 50)</td><td>1000000188</td><td></td></tr><tr><td>Sterile hyposermic syringe for single use 26G</td><td>Shanghai Misawa Medical Industry</td><td>None</td><td></td></tr><tr><td>IVIS Spectrum In Vivo Imaging System</td><td>PerkinElmer</td><td>124262</td><td></td></tr><tr><td>Living Imaging 4.0 software</td><td>PerkinElmer</td><td>None</td><td></td></tr></tbody></table>

in vivo tracking of human adipose-derived mesenchymal stem cells in a rat knee osteoarthritis model with fluorescent lipophilic membrane dye

为了支持人脂肪源性间充质干细胞 (haMSC) 治疗膝骨关节炎 (KOA) 的临床应用, 我们研究了 haMSCs 在动物模型中的细胞持久性和分布的有效性。我们展示了一种用亲油性荧光染料标记 haMSCs 细胞膜的方法。随后, 由体内成像系统动态监测经手术诱导的 KOA 大鼠的关节内注射标记细胞。我们雇用的亲油性 carbocyanines 做了 (DilC18 (5)), 一个远红色荧光 Dil (dialkylcarbocyanines) 模拟, 它利用红色激光, 以避免激发自然绿色自发荧光从周围的组织。此外, 红移发射光谱的确有允许深层成像在活体动物和标记程序没有造成细胞毒作用或功能损害 haMSCs。这种方法已被证明是一种有效的跟踪方法的 haMSCs 在大鼠 KOA 模型。该方法的应用也可用于确定临床前研究中其他来源的骨髓间充质干细胞的最佳用药路线和剂量。

为了诱导 KOA 模型, MM 在 SD 大鼠的右膝关节中进行 (图 3)。术后八周, 对大鼠进行了牺牲, 并用 H 和 #38 对膝关节的连续段进行了评价; E 和红 O/快速绿色染色 (图 4)。对于 H 和 #38; E 染色, 关节软骨的表面在手术膝部比正常关节表现出更粗糙的边界而不进行手术。对于红/快速绿色染色, 我们观察到在手术关节中, 与正常对照组相比, ?...

Watch this Scientific Journal Video about In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye at JoVE.com

In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye

在体内荧光亲脂膜染料对大鼠膝骨关节炎模型中人脂肪间充质干细胞的追踪

该协议描述了一种有效的方法来监测人脂肪来源的骨髓间充质干细胞 (haMSCs) 的细胞持久性和分布的远红色荧光标记的大鼠膝骨关节炎 (KOA) 模型通过关节内 (IA) 注射。

In order to support the clinical application of human adipose-derived mesenchymal stem cell (haMSC) therapy for knee osteoarthritis (KOA), we examined the ...

in-vivo-tracking-human-adipose-derived-mesenchymal-stem-cells-rat

Research

JoVE Journal

Developmental Biology

In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye

8.9K 次观看.  Cellular Biomedicine Group, China. 该协议描述了一种有效的方法来监测人脂肪来源的骨髓间充质干细胞 (haMSCs) 的细胞持久性和分布的远红色荧光标记的大鼠膝骨关节炎 (KOA) 模型通过关节内 (IA) 注射。

视频: In Vivo Tracking of Human Adipose-derived Mesenchymal Stem Cells in a Rat Knee Osteoarthritis Model with Fluorescent Lipophilic Membrane Dye

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis

Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are considered the gold standard for stem cell-based tissue engineering applications. However, the process by which they must be harvested can be associated with significant donor site morbidity. In contrast, adipose-derived stromal cells (ASCs) are more readily abundant and more easily harvested, making them an appealing alternative to BM-MSCs. Like BM-MSCs, ASCs can differentiate into osteogenic lineage cells and can be used in tissue engineering applications, such as seeding onto scaffolds for use in craniofacial skeletal defects. ASCs are obtained from the stromal vascular fraction (SVF) of digested adipose tissue, which is a heterogeneous mixture of ASCs, vascular endothelial and mural cells, smooth muscle cells, pericytes, fibroblasts, and circulating cells. Flow cytometric analysis has shown that the surface marker profile for ASCs is similar to that for BM-MSCs. Despite several published reports establishing markers for the ASC phenotype, there is still a lack of consensus over profiles identifying osteoprogenitor cells in this heterogeneous population. This protocol describes how to isolate and use a subpopulation of ASCs with enhanced osteogenic capacity to repair critical-sized calvarial defects.

The transcriptional heterogeneity within human adipose-derived stromal cells can be defined on the single cell level using cell surface markers and osteogenic genes. We describe a protocol utilizing flow cytometry for the isolation of cell subpopulations with increased osteogenic potential, which may be used to enhance craniofacial skeletal reconstruction.

隔离和人力富集脂肪基质细胞的成骨增强

Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are considered the gold standard for stem cell-based tissue engineering applications. However, the ...

科研

发育生物学

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

The treatment of osteochondral articular defects has been challenging physicians for many years. The better understanding of interactions of articular cartilage and subchondral bone in recent years led to increased attention to restoration of the entire osteochondral unit. In comparison to chondral lesions the regeneration of osteochondral defects is much more complex and a far greater surgical and therapeutic challenge. The damaged tissue does not only include the superficial cartilage layer but also the subchondral bone. For deep, osteochondral damage, as it occurs for example with osteochondrosis dissecans, the full thickness of the defect needs to be replaced to restore the joint surface 1. Eligible therapeutic procedures have to consider these two different tissues with their different intrinsic healing potential 2. In the last decades, several surgical treatment options have emerged and have already been clinically established 3-6.
Autologous or allogeneic osteochondral transplants consist of articular cartilage and subchondral bone and allow the replacement of the entire osteochondral unit. The defects are filled with cylindrical osteochondral grafts that aim to provide a congruent hyaline cartilage covered surface 3,7,8. Disadvantages are the limited amount of available grafts, donor site morbidity (for autologous transplants) and the incongruence of the surface; thereby the application of this method is especially limited for large defects.
New approaches in the field of tissue engineering opened up promising possibilities for regenerative osteochondral therapy. The implantation of autologous chondrocytes marked the first cell based biological approach for the treatment of full-thickness cartilage lesions and is now worldwide established with good clinical results even 10 to 20 years after implantation 9,10. However, to date, this technique is not suitable for the treatment of all types of lesions such as deep defects involving the subchondral bone 11.
The sandwich-technique combines bone grafting with current approaches in Tissue Engineering 5,6. This combination seems to be able to overcome the limitations seen in osteochondral grafts alone. After autologous bone grafting to the subchondral defect area, a membrane seeded with autologous chondrocytes is sutured above and facilitates to match the topology of the graft with the injured site. Of course, the previous bone reconstruction needs additional surgical time and often even an additional surgery. Moreover, to date, long-term data is missing 12.
Tissue Engineering without additional bone grafting aims to restore the complex structure and properties of native articular cartilage by chondrogenic and osteogenic potential of the transplanted cells. However, again, it is usually only the cartilage tissue that is more or less regenerated. Additional osteochondral damage needs a specific further treatment. In order to achieve a regeneration of the multilayered structure of osteochondral defects, three-dimensional tissue engineered products seeded with autologous/allogeneic cells might provide a good regeneration capacity 11.
Beside autologous chondrocytes, mesenchymal stem cells (MSC) seem to be an attractive alternative for the development of a full-thickness cartilage tissue. In numerous preclinical in vitro and in vivo studies, mesenchymal stem cells have displayed excellent tissue regeneration potential 13,14. The important advantage of mesenchymal stem cells especially for the treatment of osteochondral defects is that they have the capacity to differentiate in osteocytes as well as chondrocytes. Therefore, they potentially allow a multilayered regeneration of the defect.
In recent years, several scaffolds with osteochondral regenerative potential have therefore been developed and evaluated with promising preliminary results 1,15-18. Furthermore, fibrin glue as a cell carrier became one of the preferred techniques in experimental cartilage repair and has already successfully been used in several animal studies 19-21 and even first human trials 22.
The following protocol will demonstrate an experimental technique for isolating mesenchymal stem cells from a rabbit's bone marrow, for subsequent proliferation in cell culture and for preparing a standardized in vitro-model for fibrin-cell-clots. Finally, a technique for the implantation of pre-established fibrin-cell-clots into artificial osteochondral defects of the rabbit's knee joint will be described.

An experimental technique for the treatment of osteochondral defects in the rabbit's knee joint is described. The implantation of allogeneic mesenchymal stem cells into osteochondral defects provides a promising development in the field of tissue engineering. The preparation of fibrin-cell-clots in vitro offers a standardized method for implantation.

异基因骨髓间充质干细胞植入兔子的膝关节软骨缺损治疗纤维蛋白凝块

The treatment of osteochondral articular defects has been challenging physicians for many years. The better understanding of interactions of articular ...

医学

Implantation of Ferumoxides Labeled Human Mesenchymal Stem Cells in Cartilage Defects

The field of tissue engineering integrates the principles of engineering, cell biology and medicine towards the regeneration of specific cells and functional tissue. Matrix associated stem cell implants (MASI) aim to regenerate cartilage defects due to arthritic or traumatic joint injuries. Adult mesenchymal stem cells (MSCs) have the ability to differentiate into cells of the chondrogenic lineage and have shown promising results for cell-based articular cartilage repair technologies. Autologous MSCs can be isolated from a variety of tissues, can be expanded in cell cultures without losing their differentiation potential, and have demonstrated chondrogenic differentiation in vitro and in vivo1, 2.
In order to provide local retention and viability of transplanted MSCs in cartilage defects, a scaffold is needed, which also supports subsequent differentiation and proliferation. The architecture of the scaffold guides tissue formation and permits the extracellular matrix, produced by the stem cells, to expand. Previous investigations have shown that a 2% agarose scaffold may support the development of stable hyaline cartilage and does not induce immune responses3.
Long term retention of transplanted stem cells in MASI is critical for cartilage regeneration. Labeling of MSCs with iron oxide nanoparticles allows for long-term in vivo tracking with non-invasive MR imaging techniques4.
This presentation will demonstrate techniques for labeling MSCs with iron oxide nanoparticles, the generation of cell-agarose constructs and implantation of these constructs into cartilage defects. The labeled constructs can be tracked non-invasively with MR-Imaging.

Goal of the presentation is to demonstrate a highly reproducible method to generate matrix associated stem cell implants in cartilage defects, which can be visualized with MR imaging. Stem cells are labeled with FDA-approved Ferumoxides, mixed with agarose, implanted into cartilage defects and imaged with a 7T MR scanner.

Ferumoxides植入人类间质干细胞在软骨缺损的标记

The field of tissue engineering integrates the principles of engineering, cell biology and medicine towards the regeneration of specific cells and ...

生物学

Femur Window Chamber Model for In Vivo Cell Tracking in the Murine Bone Marrow

Bone marrow is a complex organ that contains various hematopoietic and non-hematopoietic cells. These cells are involved in many biological processes, including hematopoiesis, immune regulation and tumor regulation. Commonly used methods for understanding cellular actions in the bone marrow, such as histology and blood counts, provide static information rather than capturing the dynamic action of multiple cellular components in vivo. To complement the standard methods, a window chamber (WC)-based model was developed to enable serial in vivo imaging of cells and structures in the murine bone marrow. This protocol describes a surgical procedure for installing the WC in the femur, in order to facilitate long-term optical access to the femoral bone marrow. In particular, to demonstrate its experimental utility, this WC approach was used to image and track neutrophils within the vascular network of the femur, thereby providing a novel method to visualize and quantify immune cell trafficking and regulation in the bone marrow. This method can be applied to study various biological processes in the murine bone marrow, such as hematopoiesis, stem cell transplantation, and immune responses in pathological conditions, including cancer.

Femur Window Chamber Model for In Vivo Cell Tracking in the Murine Bone Marrow

The protocol describes a novel murine femur window chamber model that can be used to track movement of cells in the femoral bone marrow in vivo. Intravital multiphoton fluorescence microscopy is used to image three components of the femoral bone marrow (vasculature, collagen matrix, and neutrophils) over time.

股骨窗口商会模型<em&gt;在体内</em在小鼠骨髓&gt;手机跟踪

Bone marrow is a complex organ that contains various hematopoietic and non-hematopoietic cells. These cells are involved in many biological processes, ...

免疫与感染

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

Recent advances in the application of bone marrow mesenchymal stem cells (BMMSC) for the treatment of tendon and ligament injuries in the horse suggest improved outcome measures in both experimental and clinical studies. Although the BMMSC are implanted into the tendon lesion in large numbers (usually 10 - 20 million cells), only a relatively small number survive (&#60;10%) although these can persist for up to 5 months after implantation. This appears to be a common observation in other species where BMMSC have been implanted into other tissues and it is important to understand when this loss occurs, how many survive the initial implantation process and whether the cells are cleared into other organs. Tracking the fate of the cells can be achieved by radiolabeling the BMMSC prior to implantation which allows non-invasive in vivo imaging of cell location and quantification of cell numbers.
This protocol describes a cell labeling procedure that uses Technetium-99m (Tc-99m), and tracking of these cells following implantation into injured flexor tendons in horses. Tc-99m is a short-lived (t1/2 of 6.01 hr) isotope that emits gamma rays and can be internalized by cells in the presence of the lipophilic compound hexamethylpropyleneamine oxime (HMPAO). These properties make it ideal for use in nuclear medicine clinics for the diagnosis of many different diseases. The fate of the labeled cells can be followed in the short term (up to 36 hr) by gamma scintigraphy to quantify both the number of cells retained in the lesion and distribution of the cells into lungs, thyroid and other organs. This technique is adapted from the labeling of blood leukocytes and could be utilized to image implanted BMMSC in other organs.

In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy

This protocol describes the radiolabeling of equine mesenchymal stem cells and their implantation into tendon injuries in the horse in order to determine cell survival and tissue distribution using gamma scintigraphy.

在锝-99m在马腱末端标记的骨髓间充质干细胞的体内成像和跟踪

Recent advances in the application of bone marrow mesenchymal stem cells (BMMSC) for the treatment of tendon and ligament injuries in the horse suggest ...

Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases

Crohn&#39;s disease (CD) is a common chronic inflammatory disease of the small and large intestines. Murine and human mesenchymal stem cells (MSCs) have immunosuppressive potential and have been shown to suppress inflammation in mouse models of intestinal inflammation, even though the route of administration can limit their homing and effectiveness 1,3,4,5. Local application of MSCs to colonic injury models has shown greater efficacy at ameliorating inflammation in the colon. However, there is paucity of data on techniques to enhance the localization of human bone marrow-derived MSCs (hMSCs) to the small intestine, the site of inflammation in the SAMP-1/YitFc (SAMP) model of experimental Crohn&#39;s disease. This work describes a novel technique for the ultrasound-guided intracardiac injection of hMSCs in SAMP mice, a well-characterized spontaneous model of chronic intestinal inflammation. Sex- and age-matched, inflammation-free AKR/J (AKR) mice were used as controls. To analyze the biodistribution and the localization, hMSCs were transduced with a lentivirus containing a triple reporter. The triple reporter consisted of firefly luciferase (fl), for bioluminescent imaging; monomeric red fluorescent protein (mrfp), for cell sorting; and truncated herpes simplex virus thymidine kinase (ttk), for positron emission tomography (PET) imaging. The results of this study show that 24 h after the intracardiac administration, hMSCs localize in the small intestine of SAMP mice as opposed to inflammation-free AKR mice. This novel, ultrasound-guided injection of hMSCs in the left ventricle of SAMP mice ensures a high success rate of cell delivery, allowing for the rapid recovery of mice with minimal morbidity and mortality. This technique could be a useful method for the enhanced localization of MSCs in other models of small-intestinal inflammation, such as TNF&#916;RE6. Future studies will determine if the increased localization of hMSCs by intra-arterial delivery can lead to increased therapeutic efficacy.

Murine studies in models of colonic inflammation have demonstrated that a small percentage (1 - 5%) of mesenchymal stem cells (MSC) injected intravenously or intraperitoneally home to the inflamed colon1,2. This study shows that ultrasound-guided intracardiac injections of MSCs result in increased localization to the intestine.

超声引导下人骨髓间充质干细胞在实验性肠炎小鼠模型中的应用

Crohn&#39;s disease (CD) is a common chronic inflammatory disease of the small and large intestines. Murine and human mesenchymal stem cells (MSCs) have ...

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Regenerative medicine provides novel alternatives to conditions that challenge traditional treatments. The prevalence and morbidity of tendinopathy across species, combined with the limited healing properties of this tissue, have prompted the search for cellular therapies and propelled the development of experimental models to study their efficacy. Umbilical cord matrix-derived mesenchymal stem cells (UCM-MSC) are appealing candidates because they are abundant, easy to collect, circumvent the ethical concerns and risk of teratoma formation, yet resemble primitive embryonic stem cells more closely than adult tissue-derived MSCs. Significant interest has focused on chitosan as a strategy to enhance the properties of MSCs through spheroid formation. This paper details techniques to isolate UCM-MSCs, prepare spheroids on chitosan film, and analyze the effect of spheroid formation on surface marker expression. Consequently, creation of a bilateral patellar tendon injury model in rats is described for in vivo implantation of UCM-MSC spheroids formed on chitosan film. No complication was observed in the study with respect to morbidity, stress rising effects, or tissue infection. The total functional score of the operated rats at 7 days was lower than that of normal rats, but returned to normal within 28 days after surgery. Histological scores of tissue-healing confirmed the presence of a clot in treated defects evaluated at 7 days, absence of foreign body reaction, and progressing healing at 28 days. This bilateral patella tendon defect model controls inter-individual variation via creation of an internal control in each rat, was associated with acceptable morbidity, and allowed detection of differences between untreated tendons and treatments.

This paper describes the preparation and evaluation of umbilical cord matrix-derived mesenchymal stem cells spheroids with a bilateral patellar tendon defect model in a rat. This model was associated with an acceptable morbidity and was found to detect differences between untreated and treated tendons, and between the two treatments tested.

大鼠双侧髌腱损伤模型中干细胞治疗的评价

Regenerative medicine provides novel alternatives to conditions that challenge traditional treatments. The prevalence and morbidity of tendinopathy across ...

Isolation, Expansion, and Differentiation of Mesenchymal Stem Cells from the Infrapatellar Fat Pad of the Goat Stifle Joint

The IFP, present in the knee joint, serves as a promising source of MSCs. The IFP is an easily accessible tissue as it is routinely resected and discarded during arthroscopic procedures and knee replacement surgeries. Additionally, its removal is associated with minimal donor site morbidity. Recent studies have demonstrated that IFP-MSCs do not lose their proliferation capacity during in vitro expansion and have age-independent osteogenic differentiation potential. IFP-MSCs possess superior chondrogenic differentiation potential compared to bone marrow-derived MSCs (BMSCs) and adipose-derived stem cells (ADSCs). Although these cells are easily obtainable from aged and diseased patients, their effectiveness is limited. Hence, using IFP-MSCs from healthy donors is important to determine their efficacy in biomedical applications. As access to a healthy human donor is challenging, animal models could be a better alternative to enable fundamental understanding. Large animals such as dogs, horses, sheep, and goats play a crucial role in translational research. Amongst these, the goat could be a preferred model since the stifle joint of the goat has the closest anatomy to the human knee joint. Moreover, goat-IFP can fulfill the higher MSC numbers needed for tissue regeneration applications. Furthermore, low cost, availability, and compliance with the 3R principles for animal research make them an attractive model. This study demonstrates a simple protocol for isolating IFP-MSCs from the stifle joint of goats and in vitro culture conditions for their expansion and differentiation. The aseptically isolated IFP from the goat was washed, minced, and digested enzymatically. After filtration and centrifugation, the collected cells were cultured. These cells were adherent, had MSCs-like morphology, and demonstrated remarkable clonogenic ability. Further, they differentiated into adipogenic, chondrogenic, and osteogenic lineages, demonstrating their multipotency. In conclusion, the study demonstrates the isolation and expansion of MSCs, which show potential in tissue engineering and regenerative medicine applications.

Infrapatellar fat pad mesenchymal&#160;stem cells (IFP-MSCs) can be isolated easily from the infrapatellar fat pad of the knee joint. They proliferate well in vitro, form CFU-F colonies, and differentiate into adipogenic, chondrogenic, and osteogenic lineages. Herein, the methodology for the isolation, expansion, and differentiation of IFP-MSCs from goat stifle joint is provided.

山羊窒息关节髌下脂肪垫间充质干细胞的分离、扩增和分化

The IFP, present in the knee joint, serves as a promising source of MSCs. The IFP is an easily accessible tissue as it is routinely resected and discarded ...

生物工程

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Osteoarthritis (OA) is one of the most common debilitating disorders.&#160;Recently, numerous attempts have been made to improve the functions of the knees by using different forms of mesenchymal stem cells (MSCs). In Korea, bone marrow concentrates and cord blood-derived stem cells have been approved by the Korean Food and Drug Administration (KFDA) for cartilage regeneration. In addition, an adipose tissue-derived stromal vascular fraction (SVF) has been allowed by the KFDA for joint injections in human patients. Autologous adipose tissue-derived SVF contains extracellular matrix (ECM) in addition to mesenchymal stem cells. ECM excretes various cytokines that, along with hyaluronic acid (HA) and platelet-rich plasma (PRP) activated by calcium chloride, may help MSCs to regenerate cartilage and improve knee functions. In this article, we presented a protocol to improve knee functions by regenerating cartilage-like tissue in human patients with OA. The result of the protocol was first reported in 2011 followed by a few additional publications. The protocol involves liposuction to obtain autologous lipoaspirates that are mixed with collagenase. This lipoaspirates-collagenase mixture is then cut and homogenized to remove large fibrous tissue that may clog up the needle during the injection. Afterwards, the mixture is incubated to obtain adipose tissue-derived SVF. The resulting adipose tissue-derived SVF, containing both adipose tissue-derived MSCs and remnants of ECM, is injected into knees of patients, combined with HA and calcium chloride activated PRP. Included are three cases of patients who were treated with our protocol resulting in improvement of knee pain, swelling, and range of motion along with MRI evidence of hyaline cartilage-like tissue.

Here, we present a protocol to produce an adipose tissue-derived stromal vascular fraction and its application to improve knee functions by regenerating cartilage-like tissue in human patients with osteoarthritis.

制备脂肪组织基质血管部分用于潜在软骨再生的临床协议

Osteoarthritis (OA) is one of the most common debilitating disorders.&#160;Recently, numerous attempts have been made to improve the functions of the ...

Intraspinal Cavity Injection of Human Mesenchymal Stem Cells and Tracking their Migration into the Rat Brain

Mesenchymal stem cells (MSCs) have been studied for the treatment of various diseases. In neurodegenerative diseases involving defects in both the brain and the spinal cord, the route of administration is very important, because MSCs must migrate to both the brain and the spinal cord. This paper describes a method for administering MSCs into the spinal canal (intraspinal cavity injection) that can target the brain and spinal cord in a rat model. One million MSCs were injected into the spinal canals of rats at the level of lumbar vertebrae 2-3. After administration, the rats were euthanized at 0, 6, and 12 h post-injection. Optical imaging and quantitative real-time polymerase chain reaction (qPCR) were used to track the injected MSCs. The results of the present study demonstrated that MSCs administered via the spinal cavity could be detected subsequently in both the brain and spinal cord at 12 h. Intraspinal cavity injection has the advantage of not requiring general anesthesia and has few side effects. However, the drawback of the low migration rate of MSCs to the brain must be overcome.

Several routes of administration can be used to deliver mesenchymal stem cells (MSCs) to the brain. In the present study, MSCs were delivered throughout the neuraxis and brain via intra-spinal cavity injection. MSCs were injected into the spinal cavities of rats, and stem cell migration was tracked and quantified.

Mesenchymal stem cells (MSCs) have been studied for the treatment of various diseases. In neurodegenerative diseases involving defects in both the brain ...